Trials / Completed
CompletedNCT01051206
The Effect of 6% Hydroxyethyl Starch 130/0.4 on Blood Loss and Coagulation in Patients Medicated With Antiplatelet Agents Prior to Off-Pump Coronary Bypass Graft Surgery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 106 (estimated)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
HES 130/0.4 significantly solution will not affect on coagulation and blood loss in patients medicated with antiplatelet agents prior to off-pump coronary bypass surgery (OPCAB).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 6% hydroxyethyl Stach 130/0.4 | After dividing patients medicated with HES 130/0.4(maximum 33ml/kg/day) during surgery and one day after from the surgery with patients medicated with crystalloid only, compare the effect on the volume of bleeding, blood transfusion, and blood coagulation when using IV fluid. |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2010-02-01
- Completion
- 2010-02-01
- First posted
- 2010-01-18
- Last updated
- 2010-07-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01051206. Inclusion in this directory is not an endorsement.